Literature DB >> 8867377

The epidemiology of Mycobacterium leprae: recent insight.

S M van Beers1, M Y de Wit, P R Klatser.   

Abstract

Leprosy is still a health problem in many countries. Because the causative organism, Mycobacterium leprae cannot be cultured in vitro, it is virtually impossible to assess exposure, and the onset of infection and disease. As a consequence, the chain of infection, considered as the relationships between M. leprae, transmission and human host, is poorly understood. Here, we discuss a number of organism-, host- and environmental-related factors which may be incriminated in the dynamic process of the development of leprosy disease. The use of modern molecular and immunological tools has become a valuable addition to epidemiological research. Understanding of the epidemiology of leprosy is a prerequisite for effective control of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8867377     DOI: 10.1111/j.1574-6968.1996.tb08053.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  12 in total

1.  Serum anti-phenolic glycolipid-1 IgA correlates to IgM isotype in leprosy patients: a possible candidate for seroepidemiological surveys?

Authors:  Alexandre C de Macedo; Juliana A Guimarães; Raphael O Rodrigues; Thiago D V Araújo; Clodis M Tavares; Paula B Cabral; Maria Isabel de Moraes-Pinto; Aparecida T Nagao-Dias
Journal:  J Clin Lab Anal       Date:  2017-06-08       Impact factor: 2.352

2.  Personalized medicine approach in mycobacterial disease.

Authors:  Mehdi Mirsaeidi
Journal:  Int J Mycobacteriol       Date:  2012-06

3.  Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles.

Authors:  Nathan A Groathouse; Amol Amin; Maria Angela M Marques; John S Spencer; Robert Gelber; Dennis L Knudson; John T Belisle; Patrick J Brennan; Richard A Slayden
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

4.  Prospective study of serological conversion as a risk factor for development of leprosy among household contacts.

Authors:  J T Douglas; R V Cellona; T T Fajardo; R M Abalos; M V F Balagon; P R Klatser
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 5.  Human genetics of common mycobacterial infections.

Authors:  Natascha Remus; Alexandre Alcaïs; Laurent Abel
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  An orthopedic-, surgical-, and epidemiological-based investigation of leprosy, in the Tamil Nadu state of India.

Authors:  Jason Samona; Scott Samona; Cameron Samona; S Gopalakrishnan; P Shekhar; D Kubern; P S Mohan Kumar; Reza Nassiri
Journal:  Adv Orthop       Date:  2012-05-17

7.  Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study.

Authors:  Nádia C Düppre; Luiz Antonio B Camacho; Anna M Sales; Ximena Illarramendi; José Augusto C Nery; Elizabeth P Sampaio; Euzenir N Sarno; Samira Bührer-Sékula
Journal:  PLoS Negl Trop Dis       Date:  2012-06-19

8.  Geographical heterogeneity in the analysis of factors associated with leprosy in an endemic area of Brazil: are we eliminating the disease?

Authors:  Mônica Duarte-Cunha; Geraldo Marcelo da Cunha; Reinaldo Souza-Santos
Journal:  BMC Infect Dis       Date:  2015-04-25       Impact factor: 3.090

9.  Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases.

Authors:  Ana Paula Mendes Carvalho; Angélica da Conceição Oliveira Coelho Fabri; Rodrigo Corrêa Oliveira; Francisco Carlos Félix Lana
Journal:  BMC Infect Dis       Date:  2015-05-30       Impact factor: 3.090

Review 10.  Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1.

Authors:  Joel Carlos Lastória; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.